4//SEC Filing
Humer Franz B 4
Accession 0001737287-24-000079
CIK 0001737287other
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 4:05 PM ET
Size
313.1 KB
Accession
0001737287-24-000079
Insider Transaction Report
Form 4
Humer Franz B
Director
Transactions
- Sale
Common Stock
2024-12-05$2.16/sh−9,221$19,917→ 307,507 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices raging from $2.145 to $2.185, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Issuer
Allogene Therapeutics, Inc.
CIK 0001737287
Entity typeother
Related Parties
1- filerCIK 0001548072
Filing Metadata
- Form type
- 4
- Filed
- Dec 8, 7:00 PM ET
- Accepted
- Dec 9, 4:05 PM ET
- Size
- 313.1 KB